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Background: Preterm children seem to be at increased risk for autism spectrum disorders 
(ASD).
Methods: Parents of 157 children with birth weights less than 1,500 g (age 2 years, corrected 
for prematurity; 88 boys, 69 girls) completed screening questionnaires. The screening battery 
included the Modified Checklist for Autism in Toddlers (M-CHAT), Communication and 
Symbolic Behavior Scales Developmental Profile Infant-Toddler Checklist (CSBS-DP-ITC), 
and the Infant/Toddler Sensory Profile (ITSP). Children with disabilities were excluded. All 
children who screened positive on any of the screening tools were subsequently assessed by 
clinical examination including the Autism Diagnostic Observation Schedule.
Results: Fifty-six children (35.7%) screened positive on at least one of the parental screening 
questionnaires. Of the 56 children who tested positive, 33 participated in the detailed clinical 
follow-up assessment. A diagnosis of ASD was confirmed in 13 of the 33 children. The ASD 
prevalence was 9.7% of the sample. Analysis of children with and without an ASD diagnosis 
found significant differences relative to gestational age (26.9 weeks vs 28.3 weeks, P=0.033) 
and length of the stay in hospital (89.5 days vs 75.4 days, P=0.042). The screening tool with 
the most positive results was CSBS-DP-ITC (42 positive screens [PS]), followed by M-CHAT 
(28 PS), and ITSP (22 PS). Differences in the frequency of PS among the tests were significant 
(P=0.008). CSBS-DP-ITC had the highest sensitivity (0.846), followed by M-CHAT (0.692) 
and ITSP (0.462).
Conclusion: Our results indicate a higher prevalence of autism in children with birth 
weights 1,500 g at 2 years of age compared to the general population prevalence. The ASD 
diagnosis was associated with shorter gestation times and longer hospital stays. Our findings 
support the simultaneous use of more than one screening tests in order to increase screening 
sensitivity.
Keywords: autism spectrum disorders, preterm children, screening, Modified Checklist for 
Autism in Toddlers, Communication and Symbolic Behavior Scales Developmental Profile 
Infant-Toddler Checklist, Infant/Toddler Sensory Profile
Introduction
There is a growing body of evidence that preterm children with very low birth weight 
(VLBW; 1,000–1,500 g) or extremely low birth weight (ELBW; under 1,000 g) are 
at increased risk for autism spectrum disorders (ASD). Recent studies on this topic, in 
which screening results were validated with clinical examinations and/or diagnostic 
instruments, have described the prevalence of ASD among preterm births to be in the 
range 3.65%–12.9%,1–4 whereas the ASD prevalence in the general pediatric population 
has been found to be in the range 1%–1.5%.5,6
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The autistic phenotype seen in preterm children is thought 
to represent a milder form of the disorder than that seen in 
full-term children.7 Moreover, extremely preterm children 
have greater symptoms on the dimension of impaired social 
interaction and communication than on the dimension of 
repetitive or stereotyped behavior, the latter of which is a 
core symptom domain in diagnostic classifications.8 Studies 
performed on school-age children who were born preterm 
have revealed a markedly lower prevalence of ASD than 
would have been expected from the positive screen rate 
during infancy.8 The change in the expected prevalence may 
suggest that this population has the potential to “recover 
from autism”.
ASD have generally been regarded as life-long 
conditions.9 However, in recent years a significant minor-
ity of children with well-documented ASD have achieved 
recovery from the disorder (terms “best outcome” and 
“optimal outcome” have also been used).10–12 In a compre-
hensive review, Helt et al10 found that 3%–25% of children 
reportedly “lost” their ASD diagnosis and attained a normal 
range of cognitive, adaptive, and social skills. However, we 
do not yet have any specific data on recovery from autism 
in preterm children.13
The differences between preterm ASD and genuine ASD 
in the autism phenotype and/or prognosis may arise from 
a different causal pathway, ie, one that is nongenetic and 
stems from brain injuries and altered neurodevelopment 
associated with a very premature birth.14 Some authors have 
found a direct relationship between shorter gestation times 
and increased risk of ASD. Losh et al15 in a same-sex twin 
study estimated that every 100 g increase in birth weight 
provided a 13% reduction in the risk of ASD. Kuzniewicz 
et al16 found that ASD was approximately three times more 
prevalent in infants born before 27 weeks of gestation com-
pared with term infants and that each 1-week reduction in 
gestation was associated with further increases in the risk 
of ASD. Leavey et al17 also observed a gradual increase in 
ASD risk linked to shorter gestation times, which was espe-
cially apparent for cutoffs between 29 weeks and 37 weeks. 
The results were not affected by sex or measures of fetal 
growth. Buchmayer et al18 observed a different relation-
ship. They found that the increased risk of ASD related to 
preterm birth was mediated not by the gestation weeks but 
primarily by prenatal and neonatal complications, which 
occur more commonly among preterm infants. However, 
the largest study on the topic, performed by Mackay et al19 
did not identify any significant association between ASD 
risk and obstetric factors.
Other authors have emphasized the role of fetal growth 
on the risk of ASD. Moore et al20 reported that autism 
risk was increased in preterm small-for-gestational age 
(SGA; 5th percentile) infants 23–33 weeks and term large- 
for-gestational age (LGA; 95th percentile) 39–41 weeks, 
but decreased in preterm LGA infants 23–31 weeks. In a 
study by Abel et al21 ASD risk was seen to increase with fetal 
growth 1.50 standard deviations below and 2.00 standard 
deviations above the mean gestational age.
There were three aims of our study: 1) to estimate ASD 
prevalence in preterm children aged 2 years (corrected for 
prematurity); 2) to identify potential association of ASD 
diagnosis in preterm children with specific demographic and 
medical factors, such as parental age at delivery and education, 
child’s birth weight and length, gestational age at delivery, 
length of the stay in hospital, and the use of corticoids; and 
3) to compare the efficacy of three different screening tests 
in this population. The preliminary results have already been 
published,4 and now we present final data from our study.
Methods
sample
Children with birth weights less than 1,500 g were consecu-
tively recruited from March 2012 to June 2014. Three centers 
for “Newborns and Infants at Risk” participated in the study: 
the Department of Pediatrics, University Hospital Motol, 
Prague; the Department of Pediatrics and Adolescent Medi-
cine, General University Hospital, Prague; and the Department 
of Pediatrics, University Hospital, Hradec Kralove. Families 
were informed about the research project during routinely 
scheduled checkups for 2-year-old children (age corrected for 
prematurity). The 2-year (age-corrected) checkup is usually 
the last examination and assessment of preterm children in 
specialized centers for “Newborns and Infants at Risk” and 
further care is then decentralized to pediatricians along with 
the switch from corrected age to chronological age. Children 
with substantial disabilities, such as cerebral palsy or major 
vision and/or hearing impairments, were excluded.
Parents of 247 children with birth weights less than 
1,500 g agreed to participate in the study and signed informed 
consents. Of these, families of 157 children (63.6%) com-
pleted the screening questionnaires and returned them to the 
Department of Child Psychiatry. The sample consisted of   
88 boys and 69 girls, aged 2 years (corrected for prematurity).
asD screening tools
The screening battery included the Modified Checklist for 
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Symbolic Behavior Scales Developmental Profile Infant-
Toddler Checklist (CSBS-DP-ITC),23 and the Infant/Toddler 
Sensory Profile (ITSP).24 General descriptions and detailed 
information of the psychometric properties of these tests are 
given in our previous report.4
In those with positive M-CHAT screens, follow-up inter-
views, consisting of additional corresponding questions, are 
recommended. In our study, we used a follow-up clinical 
evaluation instead of the recommended telephone interview; 
however, we think this substitution improved the accuracy 
of our results.
ITSP was not originally considered a screening tool, and 
this study is probably the first to evaluate its use as a screen-
ing tool. Although our initial results did not seem to overly 
promising,4 we decided to retain ITSP in the battery in order 
to make a final analysis.
Procedure
The study was approved by the Ethics Committees of all 
three participating hospitals. Parents of VLBW and ELBW 
children (2 years of age, corrected for prematurity) who 
agreed to participate in the study signed informed consents 
and received test materials with written instructions on how to 
fill out the questionnaires. No recommendations regarding the 
order of test completion were given. Parents completed the 
screening battery of questionnaires at home and returned 
them by regular mail to the Department of Child Psychiatry, 
Motol University Hospital.
All children who had screened positive on any of the 
screening tools were subsequently invited for a detailed 
follow-up assessment. The assessment involved test-
ing using the Autism Diagnostic Observation Schedule 
(ADOS)25 and a clinical examination by two experienced 
child psychiatrists with expertise in autism. The concept of 
best estimate clinical diagnosis (BECD), by consensus of 
two experienced specialists, was used as the gold standard.26 
In cases of disagreement between the ADOS diagnosis and 
BECD, the latter was preferred. The International Classi-
fication of Diseases, Tenth Edition (ICD-10), was used for 
clinical diagnoses.27
Data analysis
Statistical analysis was performed using the Statistical 
Package for the Social Sciences (IBM SPSS, version 22.0) 
and statistical software R28 with the RVAideMemoire29 
and pROC libraries.30 Descriptive statistics for the samples 
were used. The Mann–Whitney U-test and χ2-test were 
used for analyzing the differences between subgroups with 
and without an ASD diagnosis. Cochran’s Q-test was used 
for analyzing differences in positivity among tests. More 
detailed pair comparisons between tests were performed 
using the paired Wilcoxon sign tests, with the false discov-
ery rate adjusted for multiple testing. Receiver operating 
characteristic (ROC) analysis was used in the evaluation of 
the three screening tests.
Results
asD prevalence in the sample
Fifty-six children (35.7%) screened positive on at least one 
of the screening questionnaires. Parents of 33 of the 56 
children agreed to participate in the follow-up assessment. A 
diagnosis of ASD was indicated in 15 children based on the 
ADOS, and ASD was ultimately confirmed in 13 of the 33 
children. Diagnoses, based on the ICD-10, were childhood 
autism (n=7) and atypical autism (n=6). In two cases (2 of 
15), there was a disagreement between the ADOS diagnosis 
and the BECD. In the first case, ADOS indicated ASD but 
the BECD was that of mild mental retardation. In second 
case, ADOS indicated ASD; however, no psychiatric diag-
nosis (BECD) was established. ASD prevalence calculated 
from those examined (33 children) and those with negative 
screening results (101 children) was estimated to be as high 
as 9.7% of the sample.
Demographic and medical factors
Table 1 shows the family and child characteristics for the total 
sample and for the subgroups. Based on the final diagnosis, 
two subgroups were formed. The subgroup with an ASD 
diagnosis (N=13) consisted of children who screened positive 
and when subsequently examined (ADOS and BECD) fell 
into the category of ASD. The other subgroup was without 
an ASD diagnosis (N=121) and consisted of 101 children 
who initially screened negative on all three screening tests 
as well as 20 children who initially screened positive; how-
ever, after subsequent examination, BECD failed to confirm 
a diagnosis of ASD. Children who were positive on at least 
one screening test but whose parents did not agree with 
the clinical examination (N=23) were not included in the 
subgroup analysis.
A comparison of children with and without an ASD diag-
nosis showed significant differences relative to gestational 
age (P=0.033) and length of the stay in hospital (P=0.042) 
between the two subgroups (Table 1). We found no sig-
nificant differences relative to maternal and paternal age at 
delivery, level of maternal and paternal education, mean birth 
weight and length, or the use of corticoids.Neuropsychiatric Disease and Treatment 2014:10 submit your manuscript | www.dovepress.com
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screening battery
The screening tool with the most positive results was CSBS-
DP-ITC (42 positive screens). M-CHAT had 28 positive 
screens and ITSP had 22 positive screens. For details, see 
Table 2. The difference in positive results among the screen-
ing tests was significant (P=0.008). In pair comparisons, 
using the paired Wilcoxon sign tests with the false discovery 
rate adjusted for multiple testing, CSBS-DP-ITC was found 
to be significantly more positive than both ITSP (P=0.022) 
and M-CHAT (P=0.022). The difference between M-CHAT 
and ITSP was not significant.
ROC analysis was calculated from a sample of 134 
children which consisted of the subgroup with an ASD 
diagnosis (N=13) and the subgroup without an ASD diagnosis 
(N=121); for a more detailed description of both subgroups 
see the “Demographic and medical factors” section. Table 3 
summarizes the results of the ROC analyses of individual tests 
in relation to the ASD diagnosis. CSBS-DP-ITC turned out to 
be the most sensitive tool; similarly, M-CHAT and ITSP also 
showed high levels of specificity and accuracy. Additionally, 
the negative predictive value was high for all three screening 
questionnaires; however, the positive predictive value (PPV) 
tended to be relatively low for all three tests. The second half 
of Table 3 displays the psychometric values derived from 
the combined use of the three screening tests. The first line 
in Table 3 shows results for the combined use, which is how 
it was used in our study (ie, if one of the tests was positive, 
then the screen was considered positive). The next two lines 
demonstrate how psychometric values would change relative 
to changes in the “screen positive” criteria (ie, if 2 of 3, or 3 
of 3 tests must be positive for the screen to be positive).
Discussion
Our study estimated the prevalence of ASD to be as high 
as 9.7%, a number that was lower than in our preliminary 
data (12.9%). The ASD prevalence might have been slightly 
higher if all the children with positive screens had undergone 
the clinical examination. Unfortunately, parents of a large 
Table 1 Family and child characteristics of the preterm population (age 2 years)
Sample Mean (SD) or frequency (%) Statistics
Total  
(N=157)
With ASD 
diagnosis (N=13)
Without ASD 
diagnosis (N=121)
Maternal
age at delivery (years) 32.6 (4.4) 32.3 (3.2) 32.7 (4.3) U=829.5, df=1, P=0.749
education
elementary 2 (1.3%) 0 (0%) 1 (0.8%) χ2=0.637, df=2, P=0.727
high school 89 (56.7%) 6 (46.2%) 68 (56.2%)
University 65 (41.4%) 7 (53.8%) 52 (43.0%)
Unknown 1 (0.6%) 0 (0%) 0 (0%)
Paternal
age at delivery (years) 34.8 (4.9) 33.5 (2.9) 35.0 (4.8) U=898, df=1, P=0.315
education
elementary 1 (0.6%) 0 (0%) 1 (0.8%) χ2=0.904, df=2, P=0.636
high school 90 (57.3%) 9 (69.2%) 66 (54.5%)
University 61 (38.9%) 4 (30.8%) 51 (42.2%)
Unknown 5 (3.2%) 0 (0%) 3 (2.5%)
child
Birth weight (g) 1,034.1 (283.4) 964.5 (300.4) 1,042.2 (282.3) U=898.5, df=1, P=0.402
Birth length (cm) 35.6 (3.6) 35.6 (4.1) 35.5 (3.5) U=243, df=1, P=0.883
gestational age (weeks) 28.2 (2.6) 26.9 (2.0) 28.3 (2.5) U=1,071, df=1, P=0.033
stay in hospital (days) 75.8 (29.7) 89.5 (23.9) 75.4 (29.2) U=357.5, df=1, P=0.042
Use of corticoids 39 (24.8%) 5 (38.5%) 27 (22.3%) χ2=0.914, df=2, P=0.339
Abbreviations: sD, standard deviation; asD, autism spectrum disorders; N, number of children.
Table 2 comparison of screening tools used in the preterm 
population (age 2 years)
Screening  
tool
N Positive  
screens
Negative 
screens
M-chaT 157 28 (17.8%) 129 (82.2%)
csBs-DP-iTc 155 42 (27.1%) 113 (72.9%)
iTsP 154 22 (14.3%) 132 (85.7%)
Notes: cochran’s Q-test for all three screening tools: Q=9.77, df=2, P=0.008; paired 
Wilcoxon sign test FDr (false discovery rate adjusted for multiple testing): csBs-
DP-iTc vs iTsP (P=0.022), csBs-DP-iTc vs M-chaT (P=0.022), M-chaT vs iTsP 
(P=0.522).
Abbreviations: N, number of screened children; M-CHAT, Modified Checklist for 
autism in Toddlers; csBs-DP-iTc, communication and symbolic Behavior scales 
Developmental Profile Infant-Toddler Checklist; ITSP, Infant/Toddler Sensory Profile.Neuropsychiatric Disease and Treatment 2014:10 submit your manuscript | www.dovepress.com
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proportion of children (41.1%) who screened positive did 
not bring their children in for the follow-up examination. 
Our estimated ASD prevalence in preterms was several 
times higher than in general population, which was in agree-
ment with previous findings from studies that validated the 
screening results with clinical examinations.1–3 Moreover, our 
sample of VLBW and ELBW children allowed us to establish 
an increased frequency of ASD at the age of 2 years, whereas 
the studies cited above examined either school-age children1,2 
or adolescents and those in early adulthood.3
Some may argue that certain developmental trajectories in 
preterm children are at variance with those in term children. 
Children with a “preterm behavioral phenotype” may present 
with symptoms that resemble, overlap, or even meet the cri-
teria for ASD diagnosis. Thus, more prospective studies with 
comparison groups of term children are needed in order to 
identify precisely the optimal ASD screening age for preterm 
children.13 We think that early identification of autism in pre-
terms (eg, at 2 years of corrected age, as it was in our study) 
and prospective follow-up of this group will provide valuable 
information on the stability of the diagnosis with time and on 
possible rates of “recovery from autism” in this specific group. 
Such a study is one of our long-term research aims.
Many previous studies have examined the association 
between gestational age and ASD, and some of them observed 
an increased association with autism in preterm children as 
well as post-term children. Studies by Kuzniewicz et al16 and 
Leavey et al17 found a higher prevalence of ASD associated 
with shorter gestational periods. In accordance with these 
results, we also observed an association between shorter ges-
tational age and an increased occurrence of ASD. An associa-
tion between birth weight and ASD frequency has also been 
reported in a large population-based study.15 Our study also 
found a difference in birth weight between children with and 
without ASD; however, it was not statistically significant.
In a study by Buchmayer et al18 the increased risk of autis-
tic disorders related to preterm birth was mediated primarily 
by prenatal and neonatal complications, which occurred 
more commonly among preterm infants. Kuzniewicz et al16 
retrospectively evaluated changes in ASD risks relative to 
changes in gestational age. Additionally, the study sought 
to correlate specific gestational age-related neonatal risk 
factors (ie, conditions and interventions) with changes in 
the prevalence of ASD. The study found that high-frequency 
ventilation and intracranial hemorrhage were associated 
with ASD in infants with gestation ages 34 weeks. Our 
study found an association between ASD and length of 
hospital stay, which indicated an association between ASD 
and neonatal risk factors. In a population-based cohort 
study by Moore et al20 the authors found many factors 
associated with ASD, eg, male sex, advanced maternal 
and paternal age, and twin gestation. In our study, we 
found no significant differences relative to maternal and 
paternal age at delivery or level of maternal and paternal 
education; however, this could easily be a reflection of a 
small sample size.
Our study may be the first to compare the efficacy of three 
well-established tests for use with preterms (M-CHAT and 
CSBS-DP-ITC have been well established in screening; the 
use of ITSP for screening was experimental but the test itself 
has been reliably studied). M-CHAT is the most frequently 
used parental screening test for autism. Authors of the test 
have demonstrated its high sensitivity (0.87) and specificity 
(0.99).22 Kleinman et al31 found a PPV of 0.36 for the initial 
screening which improved to 0.74 when combined with a 
follow-up interview. We used the screening questionnaire 
without a follow-up interview and found the sensitivity lower 
(0.69) than in Robins et al’s study,22 although the specificity 
was almost as high (0.93). The PPV, which tends to be low 
when the screening questionnaire is used without a follow-up 
Table 3 Psychometric values of three screening test for autism based on rOc analysis
Specificity Sensitivity PPV NPV Accuracy
single test use
M-chaT (N=134) 0.926 0.692 0.500 0.966 0.903
csBs-DP-iTc (N=132) 0.849 0.846 0.379 0.981 0.848
iTsP (N=133) 0.942 0.462 0.462 0.942 0.902
combined use of the tests with requested positivity in at least
One of the tests (N=131) 0.797 1.000 0.351 1.000 0.817
Two of the tests (N=131) 0.924 0.769 0.526 0.973 0.908
all three tests (N=131) 0.992 0.231 0.750 0.921 0.916
Notes: Due to missing data, rOc calculations for some tests did not include the full number of 134 probands.
Abbreviations: ROC, receiver operating characteristic; M-CHAT, Modified Checklist for Autism in Toddlers; CSBS-DP-ITC, Communication and Symbolic Behavior Scales 
Developmental Profile Infant-Toddler Checklist; ITSP, Infant/Toddler Sensory Profile; PPV, positive predictive value; NPV, negative predictive value; N, number of probands 
whose data entered the rOc analysis.Neuropsychiatric Disease and Treatment 2014:10 submit your manuscript | www.dovepress.com
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interview, was higher in our results (0.5) than in Kleinman 
et al’s study.31 In previous studies, 21%–41% of extremely 
preterm infants screened positive on M-CHAT; however, 
after excluding children with disabilities, the number of 
positive screens decreased to 10%–16.5%.32,33 Our study 
also excluded children with major disabilities, and 17.5% 
of our sample screened positive, a result comparable to 
previous studies.
CSBS-DP-ITC is a general broadband screen that detects 
a wide range of disorders such as global developmental delay, 
general language delay, and autism. Sensitivity estimates 
ranged from 0.87 to 0.93, and specificity was found to be 
0.75.23 In our study, the sensitivity was comparable to the 
estimated range (0.85), while the specificity was higher (0.85) 
than in Wetherby et al’s report.23 The sensitivity of CSBS-
DP-ITC test was the highest of the three screening tools used 
in our study (Table 3). The number of positive responses was 
high (27.1%). PPV specific to an ASD diagnosis was low in 
our study (0.38) compared to the PPV presented in Pierce et 
al’s report34 which used CSBS-DP-ITC for the detection of 
a wide range of disorders connected to global developmental 
impairment (PPV =0.75).
ITSP is a norm-referenced questionnaire, in which the 
caregiver rates the frequency at which the individual being 
tested engages in the described response to sensory input.24 
In extensive meta-analysis of sensory modulation symptoms 
in persons with ASD, different versions of the sensory pro-
file, including ITSP, were found to be the most frequently 
used methods for measuring sensory processing.35 Unlike 
M-CHAT and CSBS-DP-ITC, ITSP is not generally used 
for screening;36 however, early on we concluded that ITSP 
might be a useful screening tool because autistic children often 
display unusual behavioral responses to sensory input, such 
as hypersensitivity to auditory, visual, tactile, and olfactory 
stimuli.37,38 Our study may be the first to evaluate its use as 
a screening tool. We also established a new criterion for a 
positive screening. The criterion was that participants were 
considered to have screened positive if the results were defi-
nitely abnormal (ie, results outside two standard deviations 
of population norms) on at least two scores involving section 
and/or quadrant scores.4 ITSP had the lowest number of posi-
tive responses (14.3%). With regard to the lowest number of 
positive responses in comparison to the other two question-
naires, it seems that the established criteria might have been 
too strict. Test accuracy, with regard to ASD diagnosis, was 
high (0.90), and so was its specificity (0.94); both parameters 
were comparable to those of M-CHAT (Table 3). As with the 
other two tests, the negative predictive value was high (0.94) 
and the PPV was low (0.46). However, of the three tests, ITSP 
turned out to be the least sensitive (0.46) and this handicaps 
its use for general screening.
To conclude this part of the discussion, M-CHAT and 
CSBS-DP-ITC showed good psychometric properties for 
screening a preterm population. CSBS-DP-ITC had the 
highest sensitivity of the three tests we used, which could be 
outweighed by faster and easier administration of M-CHAT. 
Therefore, the selection of an appropriate screening test for 
clinical purposes should be based not only on psychometric 
properties of the tests but also on specific aims and broader 
circumstances of each screening.
To our knowledge, our results can only be compared to 
the 2012 study by Stephens et al39 who also used a screen-
ing battery instead of a single tool. They found a markedly 
smaller percentage of positive screens, with only 20% of 
infants (excluding those with disabilities) having at least 
one positive screen, whereas in our study it was 35.7% of 
children. Stephens et al reported that only 1% of the sample 
screened positive on all three screens, whereas our study 
found that 9% of participants were positive on all three 
screens. It must be noted that Stephens et al used less common 
screening instruments such as the Pervasive Developmental 
Disorder Screening Test, Second Edition Stage 2, and two 
parts from the ADOS (ie, response to name and response to 
joint attention). Despite using different screening tools, they 
reached the same conclusion as we did: that is, simultane-
ous use of more than one screening test results in a higher 
number of positive screens, which means better screening 
sensitivity.
The most noteworthy limitation of our study was the 
large number of children with positive screens who did not 
undergo clinical evaluation because of their parent’s lack 
of interest (23 from 56 or 41.1%). Additionally, we did not 
clinically examine the children who had negative screening 
results; therefore we were not able to make a valid differentia-
tion between true and false negatives in our ROC analyses. 
However, we can model this differentiation using an analysis 
of the combined use of the three tests, because there were 
children who were negative on one screening test and posi-
tive on one or both of the other screening test(s) (Table 3). 
The assessment of the combined tests are done using three 
steps, each using a different criterion for a “positive screen” 
(positive on at least one test, on at least two tests, on all three 
tests), shows us, despite the first step where the sensitiv-
ity and NPV are unrealistically high (this is direct logical Neuropsychiatric Disease and Treatment 2014:10 submit your manuscript | www.dovepress.com
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consequence of the lack of false negatives in our sample), 
that there is a potential for substantial improvement of ROC 
values (sensitivity, specificity, PPV, and NPV) when using a 
combination of screening tests. However, taking into account 
the second limitation, the psychometric values given in 
Table 3 are much stronger for mutual comparisons among the 
listed screening tests than for use as independent values.
Another issue, which was stated in the publication of 
our preliminary results,4 was that we relied solely on the 
clinical judgment of pediatricians and child neurologists 
regarding disabilities. This reliance could have affected the 
number of children excluded for major disabilities. Finally, 
there was no structured examination of motor and cognitive 
functions in our sample of children, which can be analyzed 
and presented.
Conclusion
Our results indicate a higher prevalence of autism in children 
with birth weights 1,500 g at 2 years of age compared to 
the prevalence in the general population. We found that the 
ASD diagnosis was associated with shorter gestational age 
and longer hospital stays. Our findings support the simultane-
ous use of more than one screening test in order to increase 
screening sensitivity.
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